Assessment of patient preference in allocation and observation of anti-tuberculosis medication in three districts in Tanzania

Patient Preference and Adherence

Volumn 2, Issue , 2008, Pages 1-6

  Egwaga, Saidi ^a   Range, Nyagosya ^b   Lwilla, Fred ^a   Mkopi, Abdallah ^d   Barongo, Vivien ^b   Mtenga, Sally ^c   Mshinda, Hassan ^c   Cobelens, Frank ^d,e   Haag, Vera ^f   van Leth, Frank ^d,e   Grewal, Penny ^f  

^a MINISTRY OF HEALTH AND SOCIAL WELFARE   (Tanzania)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^c IFAKARA HEALTH INSTITUTE   (Tanzania)

^d KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954746649     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Adatu F., Odeke R, Mugenyi M, et al. 2003. Implementation of the DOTS strategy for tuberculosis control in rural Kiboga District, Uganda, offering patients the option of treatment supervision in the community, 1998-1999. Int J Tuberc Lung Dis, 7(9 Suppl 1):S63-71.
2. Akkslip S., Rasmithat S, Maher D, et al. 1999. Direct observation of tuberculosis treatment by supervised family members in Yasothorn Province, Thailand. Int J Tuberc Lung Dis, 3:1061-5.
3. El-Sadr WM, Perlman DC, Denning E, et al. 2001. A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes. Clin Infect Dis, 32:623-32.
4. Frieden T. R, Sbarbaro JA. 2006. Family observation of antituberculosis treatment. Lancet, 367(9528):2055; author reply-6.
5. Garner P., Volmink J. 2006. Families help cure tuberculosis. Lancet, 367(9514):878-9.
6. Johnson J. L, Okwera A, Vjecha MJ, et al. 1997. Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis. Int J Tuberc Lung Dis, 1:446-53.
7. Kangangi J. K, Kibuga D, Muli J, et al. 2003. Decentralisation of tuberculosis treatment from the main hospitals to the peripheral health units and in the community within Machakos district, Kenya. Int J Tuberc Lung Dis, 7(9 Suppl 1):S5-13.
8. Korenromp E. L, Scano F, Williams BG, et al. 2003. Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampinbased treatment: an analytical review. Clin Infect Dis, 37:101-12.
9. Macq J. C, Theobald S, Dick J, et al. 2003. An exploration of the concept of directly observed treatment (DOT) for tuberculosis patients: from a uniform to a customised approach. Int J Tuberc Lung Dis, 7:103-9.
10. Manders A. J, Banerjee A, van den Borne HW, et al. 2001. Can guardians supervise TB treatment as well as health workers? A study on adherence during the intensive phase. Int J Tuberc Lung Dis, 5:838-42.
11. Newell J. N, Baral SC, Pande SB, et al. 2006. Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial. Lancet, 367(9514):903-9.
12. Pungrassami P., Johnsen SP, Chongsuvivatwong V, et al. 2002. Practice of directly observed treatment (DOT) for tuberculosis in southern Thailand: comparison between different types of DOT observers. Int J Tuberc Lung Dis, 6:389-95.
13. [TACAIDS] Tanzania Commission for AIDS, National Bureau of Statistics (NBS), ORC Macro. 2005. Tanzania HIV/AIDS Indicator Survey 2003-4. Calverton, Maryland USA: TACAIDS, NBS, and ORC.
14. Thiam S., LeFevre AM, Hane F, et al. 2007. Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial. JAMA, 297:380-6.
15. [WHO] World Health Organisation. 2003. Treatment of Tuberculosis: guidelines for national programmes. Geneva, Switzerland: World Health Organisation.
16. [WHO] World Health Organisation. 2006a. Mortality Country Fact sheet. Geneva, Switzerland: World Health Organization.
17. [WHO] World Health Organisation. 2006b. The Stop TB strategy. Geneva, Switzerland: World Health Organization.
18. [WHO] World Health Organisation. 2007. Global tuberculosis control: surveillance, planning, financing. Geneva, Switzerland: World Health Organization.
19. Wright J., Walley J, Philip A, et al. 2004. Direct observation of treatment for tuberculosis: a randomized controlled trial of community health workers versus family members. Trop Med Int Health, 9:559-65.